(Sharecast News) - Rapid tests developer Abingdon Health has secured a new €2.0m contract with a leading European biotech firm for the continued development and regulatory approval of a companion diagnostic lateral flow point-of-care test.
Following the successful completion of the feasibility stage of the development process, the AIM-listed group has...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE